CHINOOK THERAPEUTICS INC. (KDNY) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
4:20 pm
Sale
2020-12-3113DADURO BIOTECH, INC
ADRO
Morningside Venture (VI) Investments Ltd2,984,605
7.080%
-11,923,426decrease
(-79.98%)
Filing
History
2021-02-12
4:30 pm
Purchase
2020-12-3113GChinook Therapeutics, Inc.
KDNY
Vivo Capital IX, LLC987,624
2.300%
987,624increase
(New Position)
Filing
History
2021-02-10
6:21 pm
Purchase
2020-12-3113GChinook Therapeutics, Inc.
KDNY
Renaissance Technologies LLC836,086
1.980%
836,086increase
(New Position)
Filing
History
Goto Prev, 0, 1